Arch Venture PartnersFirm match from fund name (lower confidence)
ARCH Venture Fund XIII, L.P.
Open, writing first checks
Open: no first sale reported; age from Form D filed Feb 2024 (approximate)
- Vintage
- Unknown
- Fund size
- $3000M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Global
01 · Thesis
ARCH backs disruptive science companies, following the science to found companies based on revolutionary technologies. It takes a long-term view, sizing portfolio investments as needed and partnering through formation stages toward full potential.Inferred from the firm's website
02 · Initial check
$30M to $50M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Steve Gillis, Ph.D., Managing Director
- Mark McDonnell, Managing Director, CFO & CAO
- Keith Crandell, Co-founder & Managing Director
- Jason Doren, General Counsel
- Paul Berns, Managing Director
- Kristina Burow, Managing Director
- Robert Nelsen, Co-founder & Managing Director
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideARCH backs disruptive science companies, following the science to found companies based on revolutionary technologies.
We follow the science to found companies based on revolutionary technologies that can impact people’s lives.
https://www.archventure.com/about/
06 · Sources
Last verified: Oct 28, 2026